{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:26:54Z","timestamp":1792708014870,"version":"4.5.0"},"publisher-location":"Cham","reference-count":89,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030511395","type":"print"},{"value":"9783030511401","type":"electronic"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1007\/978-3-030-51140-1_13","type":"book-chapter","created":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T00:30:34Z","timestamp":1610497834000},"page":"201-217","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":92,"title":["Frontotemporal Lobar Degeneration TDP-43-Immunoreactive Pathological Subtypes: Clinical and Mechanistic Significance"],"prefix":"10.1007","author":[{"given":"Manuela","family":"Neumann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward B.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian R.","family":"Mackenzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,13]]},"reference":[{"issue":"Suppl 1","key":"13_CR1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/jnc.13654","volume":"138","author":"IO Woollacott","year":"2016","unstructured":"Woollacott IO, Rohrer JD (2016) The clinical spectrum of sporadic and familial forms of frontotemporal dementia. J Neurochem 138(Suppl 1):6\u201331","journal-title":"J Neurochem"},{"issue":"Suppl 1","key":"13_CR2","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/jnc.13622","volume":"138","author":"C Pottier","year":"2016","unstructured":"Pottier C, Ravenscroft TA, Sanchez-Contreras M, Rademakers R (2016) Genetics of FTLD: overview and what else we can expect from genetic studies. J Neurochem 138(Suppl 1):32\u201353","journal-title":"J Neurochem"},{"issue":"1","key":"13_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00401-008-0460-5","volume":"117","author":"IR Mackenzie","year":"2009","unstructured":"Mackenzie IR, Neumann M, Bigio EH, Cairns NJ, Alafuzoff I, Kril J et al (2009) Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendations. Acta Neuropathol 117(1):15\u201318","journal-title":"Acta Neuropathol"},{"issue":"1","key":"13_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-009-0612-2","volume":"119","author":"IR Mackenzie","year":"2010","unstructured":"Mackenzie IR, Neumann M, Bigio EH, Cairns NJ, Alafuzoff I, Kril J et al (2010) Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta Neuropathol 119(1):1\u20134","journal-title":"Acta Neuropathol"},{"issue":"5","key":"13_CR5","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s00401-006-0123-3","volume":"112","author":"IR Mackenzie","year":"2006","unstructured":"Mackenzie IR, Shi J, Shaw CL, Duplessis D, Neary D, Snowden JS et al (2006) Dementia lacking distinctive histology (DLDH) revisited. Acta Neuropathol 112(5):551\u2013559","journal-title":"Acta Neuropathol"},{"issue":"5","key":"13_CR6","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s00401-006-0138-9","volume":"112","author":"IR Mackenzie","year":"2006","unstructured":"Mackenzie IR, Baborie A, Pickering-Brown S, Du Plessis D, Jaros E, Perry RH et al (2006) Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration: classification and relation to clinical phenotype. Acta Neuropathol 112(5):539\u2013549","journal-title":"Acta Neuropathol"},{"issue":"4","key":"13_CR7","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.2353\/ajpath.2006.060438","volume":"169","author":"DM Sampathu","year":"2006","unstructured":"Sampathu DM, Neumann M, Kwong LK, Chou TT, Micsenyi M, Truax A et al (2006) Pathological heterogeneity of frontotemporal lobar degeneration with ubiquitin-positive inclusions delineated by ubiquitin immunohistochemistry and novel monoclonal antibodies. Am J Pathol 169(4):1343\u20131352","journal-title":"Am J Pathol"},{"issue":"6","key":"13_CR8","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1097\/00005072-200606000-00005","volume":"65","author":"MS Forman","year":"2006","unstructured":"Forman MS, Mackenzie IR, Cairns NJ, Swanson E, Boyer PJ, Drachman DA et al (2006) Novel ubiquitin neuropathology in frontotemporal dementia with valosin-containing protein gene mutations. J Neuropathol Exp Neurol 65(6):571\u2013581","journal-title":"J Neuropathol Exp Neurol"},{"issue":"10","key":"13_CR9","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1097\/nen.0b013e3181567f02","volume":"66","author":"IE Holm","year":"2007","unstructured":"Holm IE, Englund E, Mackenzie IR, Johannsen P, Isaacs AM (2007) A reassessment of the neuropathology of frontotemporal dementia linked to chromosome 3. J Neuropathol Exp Neurol 66(10):884\u2013891","journal-title":"J Neuropathol Exp Neurol"},{"issue":"Pt 11","key":"13_CR10","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1093\/brain\/awl271","volume":"129","author":"IR Mackenzie","year":"2006","unstructured":"Mackenzie IR, Baker M, Pickering-Brown S, Hsiung GY, Lindholm C, Dwosh E et al (2006) The neuropathology of frontotemporal lobar degeneration caused by mutations in the progranulin gene. Brain 129(Pt 11):3081\u20133090","journal-title":"Brain"},{"issue":"5796","key":"13_CR11","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1126\/science.1134108","volume":"314","author":"M Neumann","year":"2006","unstructured":"Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT et al (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314(5796):130\u2013133","journal-title":"Science"},{"key":"13_CR12","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.bbrc.2006.10.093","volume":"351","author":"T Arai","year":"2006","unstructured":"Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H et al (2006) TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 351:602\u2013611","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"13_CR13","doi-asserted-by":"publisher","first-page":"227","DOI":"10.2353\/ajpath.2007.070182","volume":"171","author":"NJ Cairns","year":"2007","unstructured":"Cairns NJ, Neumann M, Bigio EH, Holm IE, Troost D, Hatanpaa KJ et al (2007) TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions. Am J Pathol 171(1):227\u2013240","journal-title":"Am J Pathol"},{"issue":"5","key":"13_CR14","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00401-006-0189-y","volume":"113","author":"Y Davidson","year":"2007","unstructured":"Davidson Y, Kelley T, Mackenzie IR, Pickering-Brown S, Du Plessis D, Neary D et al (2007) Ubiquitinated pathological lesions in frontotemporal lobar degeneration contain the TAR DNA-binding protein, TDP-43. Acta Neuropathol 113(5):521\u2013533","journal-title":"Acta Neuropathol"},{"issue":"1","key":"13_CR15","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00401-017-1716-8","volume":"134","author":"IR Mackenzie","year":"2017","unstructured":"Mackenzie IR, Neumann M (2017) Reappraisal of TDP-43 pathology in FTLD-U subtypes. Acta Neuropathol 134(1):79\u201396","journal-title":"Acta Neuropathol"},{"issue":"1","key":"13_CR16","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41593-018-0294-y","volume":"22","author":"F Laferriere","year":"2019","unstructured":"Laferriere F, Maniecka Z, Perez-Berlanga M, Hruska-Plochan M, Gilhespy L, Hock EM et al (2019) TDP-43 extracted from frontotemporal lobar degeneration subject brains displays distinct aggregate assemblies and neurotoxic effects reflecting disease progression rates. Nat Neurosci 22(1):65\u201377","journal-title":"Nat Neurosci"},{"issue":"6","key":"13_CR17","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1007\/s00401-019-01962-9","volume":"137","author":"C Pottier","year":"2019","unstructured":"Pottier C, Ren Y, Perkerson RB 3rd, Baker M, Jenkins GD, van Blitterswijk M et al (2019) Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD. Acta Neuropathol 137(6):879\u2013899","journal-title":"Acta Neuropathol"},{"issue":"Pt 11","key":"13_CR18","doi-asserted-by":"publisher","first-page":"3380","DOI":"10.1093\/brain\/aws230","volume":"135","author":"H Tsuji","year":"2012","unstructured":"Tsuji H, Arai T, Kametani F, Nonaka T, Yamashita M, Suzukake M et al (2012) Molecular analysis and biochemical classification of TDP-43 proteinopathy. Brain 135(Pt 11):3380\u20133391","journal-title":"Brain"},{"issue":"2","key":"13_CR19","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00401-008-0477-9","volume":"117","author":"M Neumann","year":"2009","unstructured":"Neumann M, Kwong LK, Lee EB, Kremmer E, Flatley A, Xu Y et al (2009) Phosphorylation of S409\/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies. Acta Neuropathol 117(2):137\u2013149","journal-title":"Acta Neuropathol"},{"issue":"1","key":"13_CR20","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00401-011-0845-8","volume":"122","author":"IR Mackenzie","year":"2011","unstructured":"Mackenzie IR, Neumann M, Baborie A, Sampathu DM, Du Plessis D, Jaros E et al (2011) A harmonized classification system for FTLD-TDP pathology. Acta Neuropathol 122(1):111\u2013113","journal-title":"Acta Neuropathol"},{"issue":"3","key":"13_CR21","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s00401-009-0547-7","volume":"118","author":"KA Josephs","year":"2009","unstructured":"Josephs KA, Stroh A, Dugger B, Dickson DW (2009) Evaluation of subcortical pathology and clinical correlations in FTLD-U subtypes. Acta Neuropathol 118(3):349\u2013358","journal-title":"Acta Neuropathol"},{"issue":"1","key":"13_CR22","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s00401-019-02070-4","volume":"139","author":"IR Mackenzie","year":"2020","unstructured":"Mackenzie IR, Neumann M (2020) Subcortical TDP-43 pathology patterns validate cortical FTLD-TDP subtypes and demonstrate unique aspects of C9orf72 mutation cases. Acta Neuropathol 139(1):83\u201398","journal-title":"Acta Neuropathol"},{"issue":"2","key":"13_CR23","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00401-011-0839-6","volume":"122","author":"KA Josephs","year":"2011","unstructured":"Josephs KA, Hodges JR, Snowden JS, Mackenzie IR, Neumann M, Mann DM et al (2011) Neuropathological background of phenotypical variability in frontotemporal dementia. Acta Neuropathol 122(2):137\u2013153","journal-title":"Acta Neuropathol"},{"issue":"12","key":"13_CR24","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.1093\/brain\/awx254","volume":"140","author":"DC Perry","year":"2017","unstructured":"Perry DC, Brown JA, Possin KL, Datta S, Trujillo A, Radke A et al (2017) Clinicopathological correlations in behavioural variant frontotemporal dementia. Brain 140(12):3329\u20133345","journal-title":"Brain"},{"issue":"12","key":"13_CR25","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1136\/jnnp.2010.214437","volume":"82","author":"JD Rohrer","year":"2011","unstructured":"Rohrer JD, Lashley T, Holton J, Revesz T, Urwin H, Isaacs AM et al (2011) The clinical and neuroanatomical phenotype of FUS associated frontotemporal lobar degeneration. J Neurol Neurosurg Psychiatry 82(12):1405\u20131407","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Pt 3","key":"13_CR26","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1093\/brain\/awr355","volume":"135","author":"JS Snowden","year":"2012","unstructured":"Snowden JS, Rollinson S, Thompson JC, Harris JM, Stopford CL, Richardson AM et al (2012) Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations. Brain 135(Pt 3):693\u2013708","journal-title":"Brain"},{"issue":"1","key":"13_CR27","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/cge.13095","volume":"93","author":"E Al-Obeidi","year":"2018","unstructured":"Al-Obeidi E, Al-Tahan S, Surampalli A, Goyal N, Wang AK, Hermann A et al (2018) Genotype-phenotype study in patients with valosin-containing protein mutations associated with multisystem proteinopathy. Clin Genet 93(1):119\u2013125","journal-title":"Clin Genet"},{"issue":"2","key":"13_CR28","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1097\/nen.0b013e31803020b9","volume":"66","author":"M Neumann","year":"2007","unstructured":"Neumann M, Mackenzie IR, Cairns NJ, Boyer PJ, Markesbery WR, Smith CD et al (2007) TDP-43 in the ubiquitin pathology of frontotemporal dementia with VCP gene mutations. J Neuropathol Exp Neurol 66(2):152\u2013157","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"13_CR29","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/j.1440-1789.2012.01332.x","volume":"33","author":"EH Bigio","year":"2013","unstructured":"Bigio EH, Weintraub S, Rademakers R, Baker M, Ahmadian SS, Rademaker A et al (2013) Frontotemporal lobar degeneration with TDP-43 proteinopathy and chromosome 9p repeat expansion in C9ORF72: clinicopathologic correlation. Neuropathology 33(2):122\u2013133","journal-title":"Neuropathology"},{"issue":"Pt 3","key":"13_CR30","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1093\/brain\/aws004","volume":"135","author":"BF Boeve","year":"2012","unstructured":"Boeve BF, Boylan KB, Graff-Radford NR, DeJesus-Hernandez M, Knopman DS, Pedraza O et al (2012) Characterization of frontotemporal dementia and\/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72. Brain 135(Pt 3):765\u2013783","journal-title":"Brain"},{"issue":"Pt 3","key":"13_CR31","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1093\/brain\/awr361","volume":"135","author":"CJ Mahoney","year":"2012","unstructured":"Mahoney CJ, Beck J, Rohrer JD, Lashley T, Mok K, Shakespeare T et al (2012) Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features. Brain 135(Pt 3):736\u2013750","journal-title":"Brain"},{"issue":"6","key":"13_CR32","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s00401-011-0907-y","volume":"122","author":"ME Murray","year":"2011","unstructured":"Murray ME, Dejesus-Hernandez M, Rutherford NJ, Baker M, Duara R, Graff-Radford NR et al (2011) Clinical and neuropathologic heterogeneity of c9FTD\/ALS associated with hexanucleotide repeat expansion in C9ORF72. Acta Neuropathol 122(6):673\u2013690","journal-title":"Acta Neuropathol"},{"issue":"24","key":"13_CR33","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1212\/WNL.0000000000002220","volume":"85","author":"I Gijselinck","year":"2015","unstructured":"Gijselinck I, Van Mossevelde S, van der Zee J, Sieben A, Philtjens S, Heeman B et al (2015) Loss of TBK1 is a frequent cause of frontotemporal dementia in a Belgian cohort. Neurology 85(24):2116\u20132125","journal-title":"Neurology"},{"key":"13_CR34","doi-asserted-by":"crossref","unstructured":"Hirsch-Reinshagen V, Alfaify OA, Hsiung GR, Pottier C, Baker M, Perkerson RB 3rd et al (2019) Clinicopathologic correlations in a family with a TBK1 mutation presenting as primary progressive aphasia and primary lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 20:568\u2013575","DOI":"10.1080\/21678421.2019.1632347"},{"key":"13_CR35","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.dadm.2016.10.003","volume":"6","author":"CA Koriath","year":"2017","unstructured":"Koriath CA, Bocchetta M, Brotherhood E, Woollacott IO, Norsworthy P, Simon-Sanchez J et al (2017) The clinical, neuroanatomical, and neuropathologic phenotype of TBK1-associated frontotemporal dementia: a longitudinal case report. Alzheimers Dement (Amst) 6:75\u201381","journal-title":"Alzheimers Dement (Amst)"},{"issue":"3","key":"13_CR36","doi-asserted-by":"publisher","first-page":"a003913","DOI":"10.1101\/mcs.a003913","volume":"5","author":"R Lamb","year":"2019","unstructured":"Lamb R, Rohrer JD, Real R, Lubbe SJ, Waite AJ, Blake DJ et al (2019) A novel TBK1 mutation in a family with diverse frontotemporal dementia spectrum disorders. Cold Spring Harb Mol Case Stud 5(3):a003913","journal-title":"Cold Spring Harb Mol Case Stud"},{"issue":"7","key":"13_CR37","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1007\/s00702-014-1304-1","volume":"122","author":"I Alafuzoff","year":"2015","unstructured":"Alafuzoff I, Pikkarainen M, Neumann M, Arzberger T, Al-Sarraj S, Bodi I et al (2015) Neuropathological assessments of the pathology in frontotemporal lobar degeneration with TDP43-positive inclusions: an inter-laboratory study by the BrainNet Europe consortium. J Neural Transm 122(7):957\u2013972","journal-title":"J Neural Transm"},{"issue":"4","key":"13_CR38","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1097\/NEN.0b013e31816a1da2","volume":"67","author":"M Pikkarainen","year":"2008","unstructured":"Pikkarainen M, Hartikainen P, Alafuzoff I (2008) Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions visualized with ubiquitin-binding protein p62 immunohistochemistry. J Neuropathol Exp Neurol 67(4):280\u2013298","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"13_CR39","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1177\/0891988714554710","volume":"28","author":"S Shinagawa","year":"2015","unstructured":"Shinagawa S, Naasan G, Karydas AM, Coppola G, Pribadi M, Seeley WW et al (2015) Clinicopathological study of patients with C9ORF72-associated frontotemporal dementia presenting with delusions. J Geriatr Psychiatry Neurol 28(2):99\u2013107","journal-title":"J Geriatr Psychiatry Neurol"},{"issue":"1","key":"13_CR40","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00401-017-1679-9","volume":"134","author":"EB Lee","year":"2017","unstructured":"Lee EB, Porta S, Michael Baer G, Xu Y, Suh E, Kwong LK et al (2017) Expansion of the classification of FTLD-TDP: distinct pathology associated with rapidly progressive frontotemporal degeneration. Acta Neuropathol 134(1):65\u201378","journal-title":"Acta Neuropathol"},{"issue":"1","key":"13_CR41","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s40478-016-0335-2","volume":"4","author":"R Takeuchi","year":"2016","unstructured":"Takeuchi R, Tada M, Shiga A, Toyoshima Y, Konno T, Sato T et al (2016) Heterogeneity of cerebral TDP-43 pathology in sporadic amyotrophic lateral sclerosis: evidence for clinico-pathologic subtypes. Acta Neuropathol Commun 4(1):61","journal-title":"Acta Neuropathol Commun"},{"issue":"12","key":"13_CR42","doi-asserted-by":"publisher","first-page":"e1354","DOI":"10.1212\/WNL.0000000000007146","volume":"92","author":"RH Tan","year":"2019","unstructured":"Tan RH, Guennewig B, Dobson-Stone C, Kwok JBJ, Kril JJ, Kiernan MC et al (2019) The underacknowledged PPA-ALS: a unique clinicopathologic subtype with strong heritability. Neurology 92(12):e1354\u2013e1e66","journal-title":"Neurology"},{"issue":"2","key":"13_CR43","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s00702-009-0350-6","volume":"117","author":"RA Armstrong","year":"2010","unstructured":"Armstrong RA, Ellis W, Hamilton RL, Mackenzie IR, Hedreen J, Gearing M et al (2010) Neuropathological heterogeneity in frontotemporal lobar degeneration with TDP-43 proteinopathy: a quantitative study of 94 cases using principal components analysis. J Neural Transm (Vienna) 117(2):227\u2013239","journal-title":"J Neural Transm (Vienna)"},{"issue":"1","key":"13_CR44","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s00401-019-02024-w","volume":"138","author":"Y Nishihira","year":"2019","unstructured":"Nishihira Y, Gefen T, Mao Q, Appin C, Kohler M, Walker J et al (2019) Revisiting the utility of TDP-43 immunoreactive (TDP-43-ir) pathology to classify FTLD-TDP subtypes. Acta Neuropathol 138(1):167\u2013169","journal-title":"Acta Neuropathol"},{"key":"13_CR45","doi-asserted-by":"crossref","unstructured":"Clark CN, Quaegebeur A, Nirmalananthan N, MacKinnon AD, Revesz T, Holton JL et al (2019) Foix-Chavany-Marie syndrome due to type E TDP43 pathology. Neuropathol Appl Neurobio l46(3):292\u2013295.","DOI":"10.1111\/nan.12579"},{"issue":"2","key":"13_CR46","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1155\/2006\/320638","volume":"17","author":"N Ihori","year":"2006","unstructured":"Ihori N, Araki S, Ishihara K, Kawamura M (2006) A case of frontotemporal lobar degeneration with progressive dysarthria. Behav Neurol 17(2):97\u2013104","journal-title":"Behav Neurol"},{"issue":"3","key":"13_CR47","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00401-007-0331-5","volume":"115","author":"EB Lee","year":"2008","unstructured":"Lee EB, Lee VM, Trojanowski JQ, Neumann M (2008) TDP-43 immunoreactivity in anoxic, ischemic and neoplastic lesions of the central nervous system. Acta Neuropathol 115(3):305\u2013311","journal-title":"Acta Neuropathol"},{"issue":"1","key":"13_CR48","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/83679","volume":"27","author":"M Brenner","year":"2001","unstructured":"Brenner M, Johnson AB, Boespflug-Tanguy O, Rodriguez D, Goldman JE, Messing A (2001) Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease. Nat Genet 27(1):117\u2013120","journal-title":"Nat Genet"},{"issue":"19","key":"13_CR49","doi-asserted-by":"publisher","first-page":"6448","DOI":"10.1523\/JNEUROSCI.0248-14.2014","volume":"34","author":"AK Walker","year":"2014","unstructured":"Walker AK, Daniels CM, Goldman JE, Trojanowski JQ, Lee VM, Messing A (2014) Astrocytic TDP-43 pathology in Alexander disease. J Neurosci 34(19):6448\u20136458","journal-title":"J Neurosci"},{"issue":"2","key":"13_CR50","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/ng.293","volume":"41","author":"MJ Farrer","year":"2009","unstructured":"Farrer MJ, Hulihan MM, Kachergus JM, Dachsel JC, Stoessl AJ, Grantier LL et al (2009) DCTN1 mutations in Perry syndrome. Nat Genet 41(2):163\u2013165","journal-title":"Nat Genet"},{"issue":"8","key":"13_CR51","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/jnen\/nlx049","volume":"76","author":"T Mishima","year":"2017","unstructured":"Mishima T, Koga S, Lin WL, Kasanuki K, Castanedes-Casey M, Wszolek ZK et al (2017) Perry syndrome: a distinctive type of TDP-43 Proteinopathy. J Neuropathol Exp Neurol 76(8):676\u2013682","journal-title":"J Neuropathol Exp Neurol"},{"issue":"3","key":"13_CR52","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00401-013-1211-9","volume":"127","author":"KA Josephs","year":"2014","unstructured":"Josephs KA, Murray ME, Whitwell JL, Parisi JE, Petrucelli L, Jack CR et al (2014) Staging TDP-43 pathology in Alzheimer\u2019s disease. Acta Neuropathol 127(3):441\u2013450","journal-title":"Acta Neuropathol"},{"issue":"9","key":"13_CR53","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/brain\/awz224","volume":"142","author":"KA Josephs","year":"2019","unstructured":"Josephs KA, Mackenzie I, Frosch MP, Bigio EH, Neumann M, Arai T et al (2019) LATE to the PART-y. Brain 142(9):e47","journal-title":"Brain"},{"issue":"6","key":"13_CR54","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1093\/brain\/awz099","volume":"142","author":"PT Nelson","year":"2019","unstructured":"Nelson PT, Dickson DW, Trojanowski JQ, Jack CR, Boyle PA, Arfanakis K et al (2019) Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. Brain 142(6):1503\u20131527","journal-title":"Brain"},{"issue":"3","key":"13_CR55","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1080\/14728222.2018.1439923","volume":"22","author":"E Buratti","year":"2018","unstructured":"Buratti E (2018) TDP-43 post-translational modifications in health and disease. Expert Opin Ther Targets 22(3):279\u2013293","journal-title":"Expert Opin Ther Targets"},{"issue":"1","key":"13_CR56","doi-asserted-by":"publisher","first-page":"182","DOI":"10.2353\/ajpath.2008.080003","volume":"173","author":"LM Igaz","year":"2008","unstructured":"Igaz LM, Kwong LK, Xu Y, Truax AC, Uryu K, Neumann M et al (2008) Enrichment of C-terminal fragments in TAR DNA-binding protein-43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Am J Pathol 173(1):182\u2013194","journal-title":"Am J Pathol"},{"issue":"13","key":"13_CR57","doi-asserted-by":"publisher","first-page":"8516","DOI":"10.1074\/jbc.M809462200","volume":"284","author":"LM Igaz","year":"2009","unstructured":"Igaz LM, Kwong LK, Chen-Plotkin A, Winton MJ, Unger TL, Xu Y et al (2009) Expression of TDP-43 C-terminal fragments in vitro recapitulates pathological features of TDP-43 Proteinopathies. J Biol Chem 284(13):8516\u20138524","journal-title":"J Biol Chem"},{"issue":"18","key":"13_CR58","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1093\/hmg\/ddp275","volume":"18","author":"T Nonaka","year":"2009","unstructured":"Nonaka T, Kametani F, Arai T, Akiyama H, Hasegawa M (2009) Truncation and pathogenic mutations facilitate the formation of intracellular aggregates of TDP-43. Hum Mol Genet 18(18):3353\u20133364","journal-title":"Hum Mol Genet"},{"issue":"39","key":"13_CR59","doi-asserted-by":"publisher","first-page":"10530","DOI":"10.1523\/JNEUROSCI.3421-07.2007","volume":"27","author":"YJ Zhang","year":"2007","unstructured":"Zhang YJ, Xu YF, Dickey CA, Buratti E, Baralle F, Bailey R et al (2007) Progranulin mediates caspase-dependent cleavage of TAR DNA binding protein-43. J Neurosci 27(39):10530\u201310534","journal-title":"J Neurosci"},{"issue":"3","key":"13_CR60","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1111\/j.1471-4159.2009.06211.x","volume":"110","author":"D Dormann","year":"2009","unstructured":"Dormann D, Capell A, Carlson AM, Shankaran SS, Rodde R, Neumann M et al (2009) Proteolytic processing of TAR DNA binding protein-43 by caspases produces C-terminal fragments with disease defining properties independent of progranulin. J Neurochem 110(3):1082\u20131094","journal-title":"J Neurochem"},{"issue":"15\u201316","key":"13_CR61","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1002\/pmic.201200006","volume":"12","author":"JH Herskowitz","year":"2012","unstructured":"Herskowitz JH, Gozal YM, Duong DM, Dammer EB, Gearing M, Ye K et al (2012) Asparaginyl endopeptidase cleaves TDP-43 in brain. Proteomics 12(15\u201316):2455\u20132463","journal-title":"Proteomics"},{"key":"13_CR62","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1038\/ncomms2303","volume":"3","author":"T Yamashita","year":"2012","unstructured":"Yamashita T, Hideyama T, Hachiga K, Teramoto S, Takano J, Iwata N et al (2012) A role for calpain-dependent cleavage of TDP-43 in amyotrophic lateral sclerosis pathology. Nat Commun 3:1307","journal-title":"Nat Commun"},{"issue":"1","key":"13_CR63","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00401-015-1412-5","volume":"130","author":"S Xiao","year":"2015","unstructured":"Xiao S, Sanelli T, Chiang H, Sun Y, Chakrabartty A, Keith J et al (2015) Low molecular weight species of TDP-43 generated by abnormal splicing form inclusions in amyotrophic lateral sclerosis and result in motor neuron death. Acta Neuropathol 130(1):49\u201361","journal-title":"Acta Neuropathol"},{"issue":"1","key":"13_CR64","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1074\/jbc.M109.022012","volume":"285","author":"Y Nishimoto","year":"2010","unstructured":"Nishimoto Y, Ito D, Yagi T, Nihei Y, Tsunoda Y, Suzuki N (2010) Characterization of alternative isoforms and inclusion body of the TAR DNA-binding protein-43. J Biol Chem 285(1):608\u2013619","journal-title":"J Biol Chem"},{"issue":"18","key":"13_CR65","doi-asserted-by":"publisher","first-page":"7607","DOI":"10.1073\/pnas.0900688106","volume":"106","author":"YJ Zhang","year":"2009","unstructured":"Zhang YJ, Xu YF, Cook C, Gendron TF, Roettges P, Link CD et al (2009) Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity. Proc Natl Acad Sci U S A 106(18):7607\u20137612","journal-title":"Proc Natl Acad Sci U S A"},{"key":"13_CR66","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3389\/fnins.2019.00335","volume":"13","author":"BA Berning","year":"2019","unstructured":"Berning BA, Walker AK (2019) The pathobiology of TDP-43 C-terminal fragments in ALS and FTLD. Front Neurosci 13:335","journal-title":"Front Neurosci"},{"issue":"1","key":"13_CR67","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s40478-019-0755-x","volume":"7","author":"KA Josephs","year":"2019","unstructured":"Josephs KA, Zhang YJ, Baker M, Rademakers R, Petrucelli L, Dickson DW (2019) C-terminal and full length TDP-43 specie differ according to FTLD-TDP lesion type but not genetic mutation. Acta Neuropathol Commun 7(1):100","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"13_CR68","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/ana.21425","volume":"64","author":"M Hasegawa","year":"2008","unstructured":"Hasegawa M, Arai T, Nonaka T, Kametani F, Yoshida M, Hashizume Y et al (2008) Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann Neurol 64(1):60\u201370","journal-title":"Ann Neurol"},{"issue":"2","key":"13_CR69","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.bbrc.2009.03.038","volume":"382","author":"F Kametani","year":"2009","unstructured":"Kametani F, Nonaka T, Suzuki T, Arai T, Dohmae N, Akiyama H et al (2009) Identification of casein kinase-1 phosphorylation sites on TDP-43. Biochem Biophys Res Commun 382(2):405\u2013409","journal-title":"Biochem Biophys Res Commun"},{"issue":"19","key":"13_CR70","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1016\/j.febslet.2008.07.027","volume":"582","author":"Y Inukai","year":"2008","unstructured":"Inukai Y, Nonaka T, Arai T, Yoshida M, Hashizume Y, Beach TG et al (2008) Abnormal phosphorylation of Ser409\/410 of TDP-43 in FTLD-U and ALS. FEBS Lett 582(19):2899\u20132904","journal-title":"FEBS Lett"},{"key":"13_CR71","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/2051-5960-1-33","volume":"1","author":"RH Tan","year":"2013","unstructured":"Tan RH, Shepherd CE, Kril JJ, McCann H, McGeachie A, McGinley C et al (2013) Classification of FTLD-TDP cases into pathological subtypes using antibodies against phosphorylated and non-phosphorylated TDP43. Acta Neuropathol Commun 1:33","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"13_CR72","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.bbrc.2015.06.125","volume":"464","author":"KY Kim","year":"2015","unstructured":"Kim KY, Lee HW, Shim YM, Mook-Jung I, Jeon GS, Sung JJ (2015) A phosphomimetic mutant TDP-43 (S409\/410E) induces Drosha instability and cytotoxicity in neuro 2A cells. Biochem Biophys Res Commun 464(1):236\u2013243","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"13_CR73","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/j.1471-4159.2010.07098.x","volume":"116","author":"OA Brady","year":"2011","unstructured":"Brady OA, Meng P, Zheng Y, Mao Y, Hu F (2011) Regulation of TDP-43 aggregation by phosphorylation and p62\/SQSTM1. J Neurochem 116(2):248\u2013259","journal-title":"J Neurochem"},{"issue":"8","key":"13_CR74","doi-asserted-by":"publisher","first-page":"e23075","DOI":"10.1371\/journal.pone.0023075","volume":"6","author":"HY Li","year":"2011","unstructured":"Li HY, Yeh PA, Chiu HC, Tang CY, Tu BP (2011) Hyperphosphorylation as a defense mechanism to reduce TDP-43 aggregation. PLoS One 6(8):e23075","journal-title":"PLoS One"},{"issue":"4","key":"13_CR75","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1074\/mcp.M800390-MCP200","volume":"9","author":"NT Seyfried","year":"2010","unstructured":"Seyfried NT, Gozal YM, Dammer EB, Xia Q, Duong DM, Cheng D et al (2010) Multiplex SILAC analysis of a cellular TDP-43 proteinopathy model reveals protein inclusions associated with SUMOylation and diverse polyubiquitin chains. Mol Cell Proteomics 9(4):705\u2013718","journal-title":"Mol Cell Proteomics"},{"issue":"6","key":"13_CR76","doi-asserted-by":"publisher","first-page":"e38658","DOI":"10.1371\/journal.pone.0038658","volume":"7","author":"EB Dammer","year":"2012","unstructured":"Dammer EB, Fallini C, Gozal YM, Duong DM, Rossoll W, Xu P et al (2012) Coaggregation of RNA-binding proteins in a model of TDP-43 proteinopathy with selective RGG motif methylation and a role for RRM1 ubiquitination. PLoS One 7(6):e38658","journal-title":"PLoS One"},{"issue":"41","key":"13_CR77","doi-asserted-by":"publisher","first-page":"16083","DOI":"10.1074\/jbc.RA118.003440","volume":"293","author":"F Hans","year":"2018","unstructured":"Hans F, Eckert M, von Zweydorf F, Gloeckner CJ, Kahle PJ (2018) Identification and characterization of ubiquitinylation sites in TAR DNA-binding protein of 43 kDa (TDP-43). J Biol Chem 293(41):16083\u201316099","journal-title":"J Biol Chem"},{"issue":"2","key":"13_CR78","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.molcel.2011.08.025","volume":"44","author":"W Kim","year":"2011","unstructured":"Kim W, Bennett EJ, Huttlin EL, Guo A, Li J, Possemato A et al (2011) Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell 44(2):325\u2013340","journal-title":"Mol Cell"},{"issue":"10","key":"13_CR79","doi-asserted-by":"publisher","first-page":"M111 013284","DOI":"10.1074\/mcp.M111.013284","volume":"10","author":"SA Wagner","year":"2011","unstructured":"Wagner SA, Beli P, Weinert BT, Nielsen ML, Cox J, Mann M et al (2011) A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles. Mol Cell Proteomics 10(10):M111 013284","journal-title":"Mol Cell Proteomics"},{"key":"13_CR80","doi-asserted-by":"publisher","first-page":"23281","DOI":"10.1038\/srep23281","volume":"6","author":"F Kametani","year":"2016","unstructured":"Kametani F, Obi T, Shishido T, Akatsu H, Murayama S, Saito Y et al (2016) Mass spectrometric analysis of accumulated TDP-43 in amyotrophic lateral sclerosis brains. Sci Rep 6:23281","journal-title":"Sci Rep"},{"key":"13_CR81","doi-asserted-by":"publisher","first-page":"5845","DOI":"10.1038\/ncomms6845","volume":"6","author":"TJ Cohen","year":"2015","unstructured":"Cohen TJ, Hwang AW, Restrepo CR, Yuan CX, Trojanowski JQ, Lee VM (2015) An acetylation switch controls TDP-43 function and aggregation propensity. Nat Commun 6:5845","journal-title":"Nat Commun"},{"issue":"5","key":"13_CR82","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1038\/emboj.2011.471","volume":"31","author":"TJ Cohen","year":"2012","unstructured":"Cohen TJ, Hwang AW, Unger T, Trojanowski JQ, Lee VM (2012) Redox signalling directly regulates TDP-43 via cysteine oxidation and disulphide cross-linking. EMBO J 31(5):1241\u20131252","journal-title":"EMBO J"},{"issue":"7","key":"13_CR83","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/nrm2204","volume":"8","author":"A Aguzzi","year":"2007","unstructured":"Aguzzi A, Heikenwalder M, Polymenidou M (2007) Insights into prion strains and neurotoxicity. Nat Rev Mol Cell Biol 8(7):552\u2013561","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"13_CR84","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s00401-019-02077-x","volume":"138","author":"I Kawakami","year":"2019","unstructured":"Kawakami I, Arai T, Hasegawa M (2019) The basis of clinicopathological heterogeneity in TDP-43 proteinopathy. Acta Neuropathol 138(5):751\u2013770","journal-title":"Acta Neuropathol"},{"issue":"3","key":"13_CR85","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/s12031-011-9571-x","volume":"45","author":"M Hasegawa","year":"2011","unstructured":"Hasegawa M, Nonaka T, Tsuji H, Tamaoka A, Yamashita M, Kametani F et al (2011) Molecular dissection of TDP-43 proteinopathies. J Mol Neurosci 45(3):480\u2013485","journal-title":"J Mol Neurosci"},{"issue":"1","key":"13_CR86","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.celrep.2013.06.007","volume":"4","author":"T Nonaka","year":"2013","unstructured":"Nonaka T, Masuda-Suzukake M, Arai T, Hasegawa Y, Akatsu H, Obi T et al (2013) Prion-like properties of pathological TDP-43 aggregates from diseased brains. Cell Rep 4(1):124\u2013134","journal-title":"Cell Rep"},{"issue":"1","key":"13_CR87","doi-asserted-by":"publisher","first-page":"4220","DOI":"10.1038\/s41467-018-06548-9","volume":"9","author":"S Porta","year":"2018","unstructured":"Porta S, Xu Y, Restrepo CR, Kwong LK, Zhang B, Brown HJ et al (2018) Patient-derived frontotemporal lobar degeneration brain extracts induce formation and spreading of TDP-43 pathology in vivo. Nat Commun 9(1):4220","journal-title":"Nat Commun"},{"issue":"1","key":"13_CR88","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s40478-017-0454-4","volume":"5","author":"YS Davidson","year":"2017","unstructured":"Davidson YS, Robinson AC, Flood L, Rollinson S, Benson BC, Asi YT et al (2017) Heterogeneous ribonuclear protein E2 (hnRNP E2) is associated with TDP-43-immunoreactive neurites in semantic dementia but not with other TDP-43 pathological subtypes of frontotemporal lobar degeneration. Acta Neuropathol Commun 5(1):54","journal-title":"Acta Neuropathol Commun"},{"key":"13_CR89","doi-asserted-by":"publisher","first-page":"551","DOI":"10.3389\/fnins.2019.00551","volume":"13","author":"W Kattuah","year":"2019","unstructured":"Kattuah W, Rogelj B, King A, Shaw CE, Hortobagyi T, Troakes C (2019) Heterogeneous nuclear ribonucleoprotein E2 (hnRNP E2) is a component of TDP-43 aggregates specifically in the a and C pathological subtypes of frontotemporal lobar degeneration. Front Neurosci 13:551","journal-title":"Front Neurosci"}],"container-title":["Advances in Experimental Medicine and Biology","Frontotemporal Dementias"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-51140-1_13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T03:53:32Z","timestamp":1674878012000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-030-51140-1_13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9783030511395","9783030511401"],"references-count":89,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-51140-1_13","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"13 January 2021","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}